Full-Time

Principal Scientist

Mixed Modalities, Sterile Product Development

Posted on 4/10/2025

MSD

MSD

Compensation Overview

$169.7k - $267.2k/yr

+ Bonus + Long Term Incentive

Senior, Expert

H1B Sponsorship Available

Linden, NJ, USA

Hybrid work model consisting of three total days on-site per week, Monday - Thursday, with Friday designated as a remote-working day.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Requirements
  • Ph.D. with 8+ years industry experience, M.S. with 10+ years, or B.S. with 14+ years with a degree in Chemical / Biochemical Engineering, Pharmaceutics, Pharmaceutical Chemistry, Pharmaceutical Sciences, Chemistry, Biochemistry or related discipline
  • Deep drug product development expertise with exposure to all stages and aspects of development (preclinical, clinical, and commercial) and cGMP industrial background
  • Demonstrated scientific leadership and a strong track record in parenteral formulation and process development reflected through industry experience and external publications and patents, including development of sterile products for IV, IM, and/or SC route of administration (liquid and lyophilized)
  • Experience, desire, and a track record of effective mentorship of junior scientists towards timebound goals
  • Strong knowledge of QbD principles and experience applying the QbD tools to drug product development, and experience in designing appropriate DOE studies to inform on risks
  • Experience with process scale-up, definition of critical attributes, and technology transfer of early phase and/or late phase drug product manufacturing processes to GMP production facilities
  • Experience authoring regulatory filings, and demonstrated working knowledge of FDA, ICH, and other regulatory requirements for CMC. Strong understanding of integration and partnering with Quality, Regulatory, Operations, Non-clinical, Clinical, and other functional areas
  • Demonstrated experience leading cross-functional teams and driving key capability evaluations and technology selection / builds
  • Excellent verbal and written communication skills, demonstrated initiative, strong interpersonal and collaboration skills, and a strong desire to learn and contribute.
Responsibilities
  • Be a seasoned formulation scientist responsible for the design and development of sterile products across injectable, implantable, ophthalmic, and inhaled dosage forms.
  • Provide active strategic and technical leadership on program development teams, interfacing with key stakeholders, and collaborating across functions to drive defined milestones.
  • Support both early and late-stage development candidates, including screening and development of robust drug product composition, scalable process, primary packaging, compatibility characterization for processing and administration, and supporting regulatory filings.
  • Collaborate with key stakeholders across the organizations (Research Division / Manufacturing Division) to drive key capability evaluations / builds and champion strategic and innovation objectives aligned with organizational goals.
  • Maintain a strong network internally and across the external academic and regulatory community and build collaborations across internal company departments and key stakeholders.
  • Mentor and/or supervise a small group of scientists to perform the above duties and to develop the above capabilities.
Desired Qualifications
  • Experience with intermediate modalities (including oligonucleotides and peptides), non-conventional sterile dosage forms (including ocular and inhaled products), and/or alternate delivery technologies (e.g., high concentration, hydrogels, emulsions, suspensions, injectable depot)
  • Experience influencing regulatory strategies and a track record of supporting global filings
  • Experience on a large capital project team, knowledgeable of the Sterile Standards and equipment design standards, and understanding of project / engineering work process and deliverables (e.g., equipment fabrication, FAT, SAT, qualification / validation)

Company Size

N/A

Company Stage

N/A

Total Funding

N/A

Headquarters

N/A

Founded

N/A

INACTIVE